80 related articles for article (PubMed ID: 19786087)
1. Induction of apoptosis by esculetin in human leukemia U937 cells: roles of Bcl-2 and extracellular-regulated kinase signaling.
Park C; Jin CY; Kwon HJ; Hwang HJ; Kim GY; Choi IW; Kwon TK; Kim BW; Kim WJ; Choi YH
Toxicol In Vitro; 2010 Mar; 24(2):486-94. PubMed ID: 19786087
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK.
Park C; Jin CY; Kim GY; Choi IW; Kwon TK; Choi BT; Lee SJ; Lee WH; Choi YH
Toxicol Appl Pharmacol; 2008 Mar; 227(2):219-28. PubMed ID: 18031783
[TBL] [Abstract][Full Text] [Related]
3. Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells.
Jin CY; Park C; Lee JH; Chung KT; Kwon TK; Kim GY; Choi BT; Choi YH
Toxicol In Vitro; 2009 Mar; 23(2):259-65. PubMed ID: 19124070
[TBL] [Abstract][Full Text] [Related]
4. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
[TBL] [Abstract][Full Text] [Related]
5. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
Hao JH; Yu M; Liu FT; Newland AC; Jia L
Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells.
Lin TH; Lu FJ; Yin YF; Tseng TH
Chem Biol Interact; 2009 Jun; 180(1):61-8. PubMed ID: 19428345
[TBL] [Abstract][Full Text] [Related]
8. Involvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human leukemia U937 cells.
Lee SH; Park C; Jin CY; Kim GY; Moon SK; Hyun JW; Lee WH; Choi BT; Kwon TK; Yoo YH; Choi YH
Biomed Pharmacother; 2008 Dec; 62(10):723-9. PubMed ID: 18222060
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis by streptochlorin isolated from Streptomyces sp. in human leukemic U937 cells.
Park C; Shin HJ; Kim GY; Kwon TK; Nam TJ; Kim SK; Cheong J; Choi IW; Choi YH
Toxicol In Vitro; 2008 Sep; 22(6):1573-81. PubMed ID: 18639625
[TBL] [Abstract][Full Text] [Related]
10. Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt.
Moon DO; Park SY; Heo MS; Kim KC; Park C; Ko WS; Choi YH; Kim GY
Int Immunopharmacol; 2006 Dec; 6(12):1796-807. PubMed ID: 17052670
[TBL] [Abstract][Full Text] [Related]
11. Propofol protects hepatic L02 cells from hydrogen peroxide-induced apoptosis via activation of extracellular signal-regulated kinases pathway.
Wang H; Xue Z; Wang Q; Feng X; Shen Z
Anesth Analg; 2008 Aug; 107(2):534-40. PubMed ID: 18633031
[TBL] [Abstract][Full Text] [Related]
12. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
An J; Chervin AS; Nie A; Ducoff HS; Huang Z
Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: a promising new approach to the treatment of multidrug resistant cancer.
Su Y; Zhang X; Sinko PJ
Cancer Lett; 2007 Aug; 253(1):115-23. PubMed ID: 17349740
[TBL] [Abstract][Full Text] [Related]
14. A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia.
Contractor R; Samudio IJ; Estrov Z; Harris D; McCubrey JA; Safe SH; Andreeff M; Konopleva M
Cancer Res; 2005 Apr; 65(7):2890-8. PubMed ID: 15805291
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J
Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
[TBL] [Abstract][Full Text] [Related]
18. HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death.
Lickliter JD; Wood NJ; Johnson L; McHugh G; Tan J; Wood F; Cox J; Wickham NW
Leukemia; 2003 Nov; 17(11):2074-80. PubMed ID: 12931228
[TBL] [Abstract][Full Text] [Related]
19. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
Liu WH; Cheng YC; Chang LS
J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
[TBL] [Abstract][Full Text] [Related]
20. Differential induction of apoptosis and MAP kinase signaling by mitochondrial toxicants in drug-sensitive compared to drug-resistant B-lineage lymphoid cell lines.
O'Brien KA; Muscarella DE; Bloom SE
Toxicol Appl Pharmacol; 2001 Aug; 174(3):245-56. PubMed ID: 11485385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
